Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Revenue (2016 - 2025)

Marimed has reported Revenue over the past 15 years, most recently at $41.6 million for Q4 2025.

  • Quarterly Revenue rose 6.93% to $41.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $160.0 million through Dec 2025, up 1.31% year-over-year, with the annual reading at $159.8 million for FY2025, 1.34% up from the prior year.
  • Revenue was $41.6 million for Q4 2025 at Marimed, up from $40.8 million in the prior quarter.
  • Over five years, Revenue peaked at $41.6 million in Q4 2025 and troughed at $24.6 million in Q1 2021.
  • The 5-year median for Revenue is $37.2 million (2023), against an average of $36.1 million.
  • Year-over-year, Revenue soared 238.9% in 2021 and then fell 2.05% in 2025.
  • A 5-year view of Revenue shows it stood at $31.0 million in 2021, then increased by 15.42% to $35.8 million in 2022, then grew by 8.57% to $38.9 million in 2023, then increased by 0.13% to $38.9 million in 2024, then rose by 6.93% to $41.6 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Revenue are $41.6 million (Q4 2025), $40.8 million (Q3 2025), and $39.6 million (Q2 2025).